Stress Incontinence vs Urge Incontinence: Key Differences Explained
Stress incontinence and urge incontinence are the two most common types of urinary incontinence, and they are frequently confused — by patients who are unsure which type they have, and sometimes by clinicians who do not systematically characterize the incontinence type before prescribing treatment. The confusion is consequential: the causes, mechanisms, and treatments of stress incontinence and urge incontinence are fundamentally different, and the interventions that effectively treat one type typically have little or no benefit for the other. A woman who has stress incontinence but receives bladder relaxant medications (which target urgency incontinence) will not improve and may experience side effects without benefit. A woman who has urgency incontinence but undergoes a midurethral sling (which treats stress incontinence) may have no improvement in urgency and may develop new voiding dysfunction. Correct identification of the incontinence type is the prerequisite for effective treatment — not a formality, but a clinical necessity.
The distinction between stress and urge incontinence is usually apparent from the history: what triggers the leakage, and is there a preceding urgency sensation? Stress incontinence leaks during physical exertion — coughing, sneezing, laughing, lifting, jumping, running — without any preceding urgency; the patient simply leaks when intra-abdominal pressure spikes. Urgency incontinence leaks in association with a sudden, compelling urgency to void that the patient cannot suppress long enough to reach the toilet — the leakage may occur on the way to the bathroom, or simultaneously with the urgency sensation, but urgency is always present. Many patients have both types simultaneously (mixed incontinence), and distinguishing the predominant component determines which treatment is addressed first.
Stress Urinary Incontinence: Mechanism and Causes
Stress urinary incontinence (SUI) occurs when a sudden increase in intra-abdominal pressure — from coughing, sneezing, laughing, physical exercise, lifting, or simply changing position — exceeds the urethral closure pressure at that moment, allowing urine to escape from the bladder. The term “stress” refers to physical stress on the lower urinary tract, not emotional or psychological stress. Two structural deficiencies can produce this imbalance between abdominal pressure spikes and urethral resistance: urethral hypermobility and intrinsic sphincter deficiency (ISD).
In normal anatomy, the proximal urethra and bladder neck are supported by the anterior vaginal wall, the pubourethral ligaments, and the levator ani muscle complex, holding the urethra in a retropubic position above the pelvic floor. When intra-abdominal pressure increases (during coughing or lifting), the pressure wave is transmitted equally to the bladder and the proximal urethra — because the urethra is supported above the pelvic floor, pressure on it increases proportionally to pressure on the bladder, maintaining continence. When the pelvic floor support is weakened — most commonly from vaginal childbirth trauma, which can damage the levator ani muscle, the pubourethral ligaments, and the fascial supports — the proximal urethra descends below the pelvic floor (urethral hypermobility), and the pressure transmission mechanism fails: abdominal pressure increases are transmitted to the bladder but not efficiently to the descended urethra, creating a transiently positive bladder-to-urethral pressure gradient that allows leakage. Intrinsic sphincter deficiency describes weakness in the intrinsic urethral closure mechanism itself (the urethral smooth muscle, the submucosal vascular cushion, and the mucosal coaptation) independent of urethral position — it tends to produce more severe stress incontinence (leakage with minimal exertion, or even with position change), and is associated with prior urethral surgery, radiation, or significant estrogen deficiency.
The risk factors for stress urinary incontinence reflect these mechanisms: vaginal delivery (especially multiple deliveries, large infants, prolonged second-stage labor, and instrumental delivery) is the most important cause; menopause and estrogen deficiency worsen urethral mucosal coaptation; obesity increases chronic intra-abdominal pressure; chronic cough from smoking or asthma chronically strains pelvic floor supports; and prior pelvic surgery (especially prior anti-incontinence or prolapse surgery) can alter urethral anatomy and function.
Urge Urinary Incontinence: Mechanism and Causes
Urgency urinary incontinence (UUI) occurs when the detrusor muscle (the smooth muscle of the bladder wall) contracts involuntarily and with sufficient force that the external urethral sphincter cannot maintain continence, producing leakage in conjunction with an overwhelming urgency sensation. The key structural element is the detrusor muscle itself — contracting when it should be passive — rather than any failure of the sphincter or pelvic floor support mechanism. UUI is the incontinence subtype of overactive bladder syndrome, and it shares the same underlying pathophysiology: involuntary detrusor contractions arising from neurological disinhibition (as in stroke, Parkinson’s disease, multiple sclerosis, or spinal cord injury), bladder wall changes secondary to chronic outlet obstruction (as in BPH), or idiopathic urothelial and afferent nerve dysfunction without an identifiable cause.
The distinction in mechanism between SUI and UUI has a crucial treatment implication: in SUI, the bladder itself is behaving normally (contracting only when the patient chooses to void), and the problem is structural failure of the outlet and support mechanisms; in UUI, the outlet and support mechanisms may be entirely intact, and the problem is the bladder misbehaving with unsolicited contractions. This is why pelvic floor strengthening — which strengthens the outlet and support mechanisms — is the primary conservative treatment for SUI, while bladder retraining and medications that suppress detrusor overactivity are the primary treatments for UUI. A sling that reinforces urethral support will not prevent the bladder from contracting involuntarily; a bladder relaxant will not repair a deficient sphincter mechanism.
How to Tell Which Type You Have
The most reliable way to distinguish stress from urgency incontinence in the clinical history is to ask two questions about every leakage episode: What were you doing when you leaked? and Did you feel the urge to urinate before you leaked? Stress incontinence is characterized by leakage during specific physical activities (coughing, sneezing, exercise, lifting) in the absence of any preceding urgency sensation — the patient leaks during the activity, without any prior desire to void. Urgency incontinence is characterized by a sudden, compelling urge to urinate — often arriving with little warning and difficult to suppress — followed by leakage if the toilet is not reached in time; the urgency sensation is the defining feature, and the leakage may occur seconds to minutes after the urgency begins. The 3-day voiding diary, which records the timing, voided volume, fluid intake, and circumstances of each incontinence episode (specifying whether leakage followed exertion or urgency), is the most systematic and informative tool for characterizing the incontinence type and quantifying severity.
Physical examination can identify urethral hypermobility (through the Q-tip test or clinical inspection of urethral mobility during Valsalva) and demonstrate stress incontinence directly (observing leakage from the urethra during a cough or Valsalva with the bladder full), and it assesses pelvic organ prolapse, pelvic floor muscle tone, and, in men, prostate size. Post-void residual measurement by ultrasound excludes significant urinary retention that could indicate overflow rather than stress or urgency incontinence. Urodynamic testing — measuring bladder pressure during controlled filling to demonstrate involuntary detrusor contractions (confirming urgency incontinence) or measuring urethral pressure profiles and leak point pressures (characterizing sphincter function for stress incontinence) — is the definitive diagnostic test when the history and examination are ambiguous or when surgical treatment is being planned. The urinary incontinence overview on Horizon Health Guide covers the full diagnostic evaluation in detail.
Treatment: Stress Incontinence
The evidence-based treatment ladder for stress urinary incontinence begins with conservative measures and advances to surgical intervention when conservative approaches are insufficient. Pelvic floor muscle training (PFMT) — correctly performed pelvic floor contractions (Kegel exercises) targeting the levator ani and external urethral sphincter, supervised by a pelvic floor physiotherapist with biofeedback confirmation of correct technique — is first-line treatment for all women with stress incontinence. Correctly performed PFMT reduces stress incontinence episodes by 50 to 80% and achieves complete resolution in 15 to 30% of patients; it is effective for urethral hypermobility and contributes to urethral closure during physical stress events through the reflex levator contraction that accompanies voluntary sphincter engagement. Weight loss (in overweight patients), smoking cessation (to reduce chronic cough), and management of constipation (to reduce straining) are important adjunctive measures that reduce the chronic intra-abdominal pressure loading on the pelvic floor. Topical vaginal estrogen improves urethral mucosal coaptation in postmenopausal women and reduces both urgency and stress leakage associated with genitourinary syndrome of menopause.
Surgical options for SUI are offered when PFMT and conservative measures are insufficient. The midurethral sling (retropubic or transobturator) is the most commonly performed anti-incontinence procedure globally and is the standard surgical treatment for SUI with urethral hypermobility — a narrow strip of polypropylene mesh is placed suburethrally to support the mid-urethra during physical exertion, restoring the pressure transmission mechanism. Long-term cure rates of 70 to 85% have been reported. The Burch colposuspension (retropubic suspension of the periurethral fascia to Cooper’s ligament) is an open or laparoscopic alternative with comparable long-term outcomes to the midurethral sling and is sometimes preferred in patients undergoing concurrent laparoscopic pelvic procedures. Periurethral bulking agent injection (polyacrylamide hydrogel, calcium hydroxylapatite, or polydimethylsiloxane) adds periurethral bulk to coapt the urethra and improve the intrinsic closure mechanism — it produces modest improvement in SUI with ISD and is suitable for patients who are not surgical candidates or prefer a minimally invasive office-based approach, though its efficacy is lower and durability shorter than the midurethral sling.
Treatment: Urgency Incontinence
Urgency incontinence is treated by the OAB treatment paradigm: behavioral therapy first, pharmacotherapy second, advanced interventional options third. Behavioral therapy — bladder retraining (progressive extension of the voiding interval), urgency suppression techniques (rapid pelvic floor contractions during urgency to reflexively inhibit the detrusor contraction), fluid and dietary modification, and reduction of bladder irritants — is the first-line approach and produces 50 to 80% reductions in urgency incontinence episodes in patients who adhere to the program. Antimuscarinic medications (oxybutynin, tolterodine, solifenacin, fesoterodine, darifenacin, trospium) and the beta-3 agonist mirabegron or vibegron are second-line when behavioral therapy alone is insufficient. For refractory urgency incontinence, third-line options include posterior tibial nerve stimulation (a weekly outpatient procedure using acupuncture-like electrode placement near the tibial nerve at the ankle), sacral neuromodulation (InterStim implant), and intradetrusor onabotulinumtoxinA injection (Botox), which temporarily paralyzes the overactive detrusor for 6 to 12 months per injection and achieves complete continence in 30 to 60% of patients. For further context on overactive bladder and urgency incontinence, the OAB guide on Horizon Health Guide provides comprehensive coverage. Authoritative clinical guidelines are available from the AUA/SUFU OAB guidelines and the AUA SUI guidelines, and the StatPearls urinary incontinence review provides a comprehensive evidence summary.
Sources: AUA SUI Guidelines · AUA OAB Guidelines · StatPearls — Urinary Incontinence
Mixed Incontinence: When You Have Both Types
Mixed urinary incontinence — the simultaneous presence of both stress and urgency incontinence — is the most common incontinence pattern in women seen in urogynecology and continence clinics, affecting 30 to 50% of women presenting with incontinence. It arises because the risk factors for the two types overlap: vaginal childbirth damages pelvic floor support (producing SUI) while also causing autonomic nerve injury that can contribute to detrusor overactivity (producing UUI); obesity increases intra-abdominal pressure (worsening SUI) while also driving systemic inflammation and metabolic changes that affect detrusor function (worsening UUI); menopause reduces both urethral coaptation (worsening SUI) and detrusor stability (worsening UUI). The practical challenge with mixed incontinence is treatment sequencing: treating both types simultaneously is complex, and prioritizing the more bothersome type first is the standard clinical approach.
Clinical guidelines recommend identifying the predominant component — stress or urgency — from the voiding diary and symptom history, treating it first, and then reassessing residual symptoms to determine whether the other component warrants additional targeted treatment. For women in whom urgency is predominant, bladder retraining and OAB medications are started first, and the stress component is then reassessed after behavioral treatment; for women in whom stress incontinence is predominant, PFMT is started first and urgency is reassessed after pelvic floor training (which itself has a modest beneficial effect on urgency through improved pelvic floor proprioception and reflex detrusor inhibition). The key principle is that treating only one component — even the predominant one — will improve but not resolve the total symptom burden in women with significant mixed incontinence, and a planned two-phase treatment approach produces better long-term outcomes than treating only one type and abandoning treatment when partial improvement falls short of the patient’s goals. For patients with mixed incontinence considering surgical treatment for the stress component, counseling must address the risk of de novo or worsened urgency after anti-incontinence surgery — a recognized complication that occurs in 5 to 15% of patients — and urodynamic evaluation before surgery is particularly valuable in this population to predict post-operative voiding function and urgency outcomes.
Lifestyle Modifications That Help Both Types
Certain lifestyle modifications benefit both stress and urgency incontinence through their effects on the lower urinary tract, making them important regardless of the predominant incontinence type. Weight loss in overweight individuals reduces chronic intra-abdominal pressure (improving SUI by reducing the continuous mechanical load on pelvic floor supports) and reduces systemic adipose-driven inflammation that affects detrusor stability (modestly improving UUI); clinical trials demonstrate 50 to 60% reductions in incontinence episode frequency with 5 to 10% body weight loss in obese women with incontinence. Fluid management — maintaining adequate hydration (enough to produce pale yellow urine) while avoiding excessive fluid intake, particularly in the evening — reduces total urine volume and thus the urinary urgency frequency for OAB patients, while also reducing the total number of stress leakage events driven by a fuller bladder. Constipation treatment — increasing dietary fiber, hydration, and physical activity, and using osmotic laxatives when needed — reduces the mechanical pressure of a full rectum on the bladder and reduces the need for straining during defecation that chronically loads the pelvic floor. Smoking cessation eliminates the chronic cough that continuously stresses pelvic floor supports (reducing SUI) and may reduce detrusor irritation (modest benefit for UUI). These behavioral modifications are low-cost, free of side effects, and contribute to general health improvements beyond incontinence — they should be the starting point for all patients with urinary incontinence regardless of type or severity, recommended at the first consultation and reinforced at every subsequent visit.
Understanding the distinction between stress and urge incontinence — and the different treatment approaches required for each — is the most practically important knowledge a patient can have about their incontinence before seeking evaluation. Presenting this information to a primary care provider or specialist (“I think my leakage is predominantly with coughing and exercise, without urgency before it” or “my leakage always follows a sudden urgency sensation, not physical exertion”) significantly improves the efficiency of the clinical evaluation and increases the likelihood that the correct subtype-specific treatment will be offered. The complete urinary incontinence guide on Horizon Health Guide provides additional detail on diagnosis and treatment options, and the overactive bladder guide covers the urgency and detrusor overactivity component in depth.
Urodynamic Testing: When Is It Needed?
Urodynamic testing — multichannel cystometry and uroflowmetry performed by a urologist or urogynecologist — is the definitive diagnostic test for characterizing incontinence type when the history and examination alone are insufficient. Most patients with uncomplicated, straightforward stress or urgency incontinence can be diagnosed and treated empirically without urodynamics; the test is reserved for specific clinical indications where the results will change management. These indications include: uncertain diagnosis after history, voiding diary, and examination (particularly when the patient describes mixed symptoms of equal severity and the predominant type is unclear); surgical planning (urodynamic demonstration of stress incontinence as the primary mechanism before anti-incontinence surgery reduces the risk of surgical failure and de novo urgency); prior failed anti-incontinence surgery (urodynamics helps characterize why the previous surgery failed and guide revision strategy); suspected neurogenic bladder dysfunction (urodynamics distinguishes detrusor overactivity from detrusor underactivity from detrusor-sphincter dyssynergia in neurological patients); and elevated post-void residual (to determine whether incomplete emptying is from outlet obstruction or detrusor underactivity).
The urodynamic study fills the bladder with saline through a small catheter while measuring both intravesical (bladder) and intra-abdominal (rectal) pressures simultaneously, allowing calculation of true detrusor pressure (bladder pressure minus abdominal pressure) and identification of involuntary detrusor contractions that represent urgency incontinence. Cough stress testing during the study — with the bladder at a standardized volume — demonstrates stress incontinence objectively. Voiding cystometry measures the detrusor contractility during voiding and can identify bladder outlet obstruction or detrusor underactivity that would contraindicate anti-incontinence procedures that further increase outlet resistance. The abdominal leak point pressure (the cough pressure at which stress incontinence occurs) and the maximum urethral closure pressure characterize the severity of sphincter deficiency. While urodynamic testing adds cost and inconvenience, its value in clarifying the incontinence mechanism before major surgical decisions is substantial — it is a diagnostic investment that prevents costly and distressing surgical failures in patients where the diagnosis was uncertain.
For most patients, the journey from symptom recognition to effective treatment begins with accurate identification of the incontinence type — stress, urgency, or mixed — through the clinical history and voiding diary, followed by appropriate first-line treatment targeting the identified mechanism. The resources available to patients navigating this process have improved dramatically: pelvic floor physiotherapy is increasingly accessible, OAB medications are available in generic formulations, and anti-incontinence surgical options have long-term evidence bases that allow informed decision-making. No patient with urinary incontinence should face this condition without access to the clinical information needed to understand their type and their options. The NIDDK bladder control resource provides accessible patient-facing guidance on both stress and urgency incontinence types and their management.
The Role of Voiding Diaries in Diagnosis
The 3-day voiding diary is the most informative non-invasive diagnostic tool in the evaluation of urinary incontinence and is far superior to the clinical history alone for characterizing the incontinence type, quantifying severity, and identifying patterns that guide treatment. Patients record the time of each void, the volume voided (measured by urinating into a measuring jug or graduated hat placed in the toilet), each incontinence episode and its associated circumstances (what was happening, was there preceding urgency, what activity triggered it), and fluid intake including timing and type. The diary distinguishes incontinence types — leakage associated exclusively with physical exertion points to stress incontinence; leakage consistently preceded by urgency points to urgency incontinence — while also characterizing functional bladder capacity (the typical voided volume, normally 250 to 500 mL per void), total daily urine output (to identify polyuria), and the distribution of voiding between daytime and nighttime (to distinguish OAB-related nocturia from nocturnal polyuria).
The diary also reveals behavioral patterns that contribute to incontinence: excessive fluid intake (particularly caffeinated or carbonated beverages), very frequent preemptive voiding at low bladder volumes (which reduces functional bladder capacity through progressive deconditioning), or concentrating fluid intake in the evening (driving nocturia). These behavioral patterns are directly modifiable through patient education, and the diary data allows specific, evidence-based recommendations rather than generic advice. Patients who complete a voiding diary before their initial evaluation arrive with objective data that makes the consultation substantially more productive, reduces the number of follow-up visits needed to characterize the condition, and increases the precision of the treatment recommendations. Printed or app-based voiding diary templates are available from continence organizations including the National Association for Continence and the American Urogynecologic Society, and many urology and urogynecology practices provide them as part of the initial paperwork sent to new patients. The overactive bladder guide on Horizon Health Guide and the complete urinary incontinence overview provide additional context on the diagnostic evaluation and treatment options for each incontinence type.
I’ve had ‘mixed incontinence’ written on my chart for three years and never had anyone explain what that actually means or why they’re treating it the way they are. I’ve been on an OAB medication that gives me terrible dry mouth but I also leak when I sneeze, which it doesn’t help at all. Reading this I now understand that I probably have a significant stress component that needs pelvic floor physio or possibly a sling, and the OAB med is only addressing the urgency side. The section about treating the predominant type first and reassessing is exactly the clinical framework I wish my doctor had explained to me rather than prescribing one medication for both and leaving me wondering why I was still leaking.
This article does an excellent job explaining the mechanistic distinction between SUI and UUI in terms that patients can understand and act on. The point about urodynamic testing before surgical planning is particularly important — I frequently see patients referred for sling surgery after failed conservative treatment without any urodynamic evaluation, and a proportion of those patients turn out to have significant detrusor overactivity as their predominant mechanism, for which a sling will provide minimal benefit and may worsen urgency. The description of abdominal leak point pressure and urethral closure pressure as urodynamic parameters is accurate, and it’s useful for patients to understand that these measurements help their surgeon choose between a sling and a bulking agent, or advise against surgery altogether.
Dr. Whitmore, the pre-surgical urodynamics point is one of the most clinically consequential aspects of SUI management — the 5 to 15% rate of de novo urgency after midurethral sling placement is substantially higher in patients who had occult detrusor overactivity on pre-operative urodynamics, and knowing this pre-operatively allows the surgeon to counsel the patient appropriately and potentially treat the OAB component first. Joanne, your situation — a medication that helps only part of your symptom picture — is very commonly encountered in mixed incontinence, and your insight that the stress component needs separate targeted treatment is exactly right. Pelvic floor physiotherapy assessment as a first step would clarify the relative contributions and guide whether the stress incontinence responds to conservative treatment or warrants surgical evaluation.